Search

The publication of over 100 genetic markers associated with depression has rocked the neuroscience community.

Could manipulation of micro-RNA cross-talk between astrocytes and neuronal cells yield a new therapeutic avenue for ALS?

How a combinatorial approach to assessing coronary heart disease could improve diagnosis.

We sit down with England’s Chief Scientific Officer, Professor Dame Sue Hill, to learn how genomics will influence the future of pathology.

How inhibiting both polyamine synthesis (with DFMO) and uptake (with new small molecule AMXT 1501) could delay tumor development.

Different glycosylation patterns in patients with idiopathic REM sleep behavior disorder could predict the future onset of neurodegenerative disease.

An iridium-based photodynamic drug accumulates in cancer cell nuclei – and destroys them from within.

Tomorrow’s cures for retinopathies will likely include advanced gene and cell therapies delivered by precision surgery.

With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe.

Differences in bacterial diversity in the gut could be used to identify patients with Barrett’s esophagus and esophageal cancer.